Blog Viewer

Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study

By Currents Editor posted 03-23-2022 11:57

  

Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study
Stroke (02/10/22) DOI: 10.1161/STROKEAHA.121.037541
Yaghi, Shadi; Shu, Liqi; Bakradze, Ekaterina; et al.

https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.037541 

An international retrospective study compared direct oral anticoagulants (DOACs) with warfarin in a real-world cerebral venous thrombosis (CVT) cohort. The study included 845 patients with CVT who received oral anticoagulants from January 2015 through December 2020. Among the patients, 33.0% received DOACs, 51.8% received warfarin, and 15.1% received both treatments at different times. In all, there were 5.68 recurrent thromboses, 3.77 major hemorrhages, 1.84 deaths per 100 patient-years over a median follow-up of 345 days. For the 525 patients who met the recanalization analysis inclusion criteria, 36.6% had complete recanalization, 48.2% had partial, and 15.2% had no recanalization. Overall, treatment with DOACs had a similar risk of recurrent venous thrombosis, death, and rate of partial/complete recanalization compared with warfarin; however, there was a lower risk of major hemorrhage with DOACs. Large prospective or randomized studies are needed to confirm these findings, the authors conclude.

#LiteratureWatch

FURTHER READING
Ita Muharram Sari, MD National Brain Center Prof. Dr. Mahar Mardjono Hospital (NBC) is the main referral hospital specializing in brain and nervous systems under the Ministry of Health Republic of Indonesia. As a center of excellence, NBC gives advanced clinical practice on neurological diseases, education, ...
Jiping Zhou, MD, MPH PGY-3 resident in Neurology Wayne State University/Detroit Medical Center Wazim Mohamed, MD Associate Professor of Neurology and Neurosurgery Wayne State University R oberg, Lars Egil, et al. "Prediction of Long-term Survival After Status Epilepticus Using the ACD ...
Renad Abu-Sawwa, PharmD, BCPPS University of Florida, College of Pharmacy “When you adjust for hypoalbuminemia, his phenytoin level was therapeutic at 17.5 mcg/mL following his fosphenytoin load. In addition to starting maintenance phenytoin, I would recommend initiating ketamine rather than pentobarbital ...